Search research articles
Contact Us
Filters
Showing results (71-80 of 93) with videos related to
Page
of 10
Sort By:
CNS Spectrums
|
April 15, 2014
Attitudes toward borderline personality disorder: a survey of 706 mental health clinicians
Donald W Black, Bruce Pfohl, Nancee Blum, et al.
Science Translational Medicine
|
August 2, 2013
Breaking a vicious cycle
Daniel F Hayes, Jeff Allen, Carolyn Compton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 26, 2018
Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria
Philip Bonomi, Gideon Blumenthal, Andrea Stern Ferris, et al.
European Journal of Neurology
|
November 28, 2023
Lenalidomide in the treatment of anti-myelin-associated glycoprotein neuropathy: A phase 1 study to identify the maximum tolerated dose
Amro M Stino, Naresh Bumma, Rachel Smith, et al.
Journal for Immunotherapy of Cancer
|
May 19, 2019
The promise of Immuno-oncology: implications for defining the value of cancer treatment
Howard L Kaufman, Michael B Atkins, Prasun Subedi, et al.
Cytotherapy
|
March 23, 2020
Accelerating the development of innovative cellular therapy products for the treatment of cancer
Mark D Stewart, Anne Keane, Lisa H Butterfield, et al.
Critical Reviews in Oncology/Hematology
|
October 9, 2020
International liquid biopsy standardization alliance white paper
Dana Connors, Jeff Allen, J D Alvarez, et al.
JCO Clinical Cancer Informatics
|
July 24, 2019
An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung Cancer
Mark Stewart, Andrew D Norden, Nancy Dreyer, et al.
Journal for Immunotherapy of Cancer
|
September 22, 2025
Molecular response cutoffs and ctDNA collection timepoints influence on interpretation of associations between early changes in ctDNA and overall survival in patients treated with anti-PD(L)1 and/or chemotherapy
Hillary S Andrews, Nevine Zariffa, Katherine K Nishimura, et al.
Clinical Pharmacology and Therapeutics
|
October 16, 2021
Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot
Laura Lasiter, Olga Tymejczyk, Elizabeth Garrett-Mayer, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 93) with videos related to
Sort By:
Page
of 10
CNS Spectrums
|
April 15, 2014
Attitudes toward borderline personality disorder: a survey of 706 mental health clinicians
Donald W Black, Bruce Pfohl, Nancee Blum, et al.
Science Translational Medicine
|
August 2, 2013
Breaking a vicious cycle
Daniel F Hayes, Jeff Allen, Carolyn Compton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 26, 2018
Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria
Philip Bonomi, Gideon Blumenthal, Andrea Stern Ferris, et al.
European Journal of Neurology
|
November 28, 2023
Lenalidomide in the treatment of anti-myelin-associated glycoprotein neuropathy: A phase 1 study to identify the maximum tolerated dose
Amro M Stino, Naresh Bumma, Rachel Smith, et al.
Journal for Immunotherapy of Cancer
|
May 19, 2019
The promise of Immuno-oncology: implications for defining the value of cancer treatment
Howard L Kaufman, Michael B Atkins, Prasun Subedi, et al.
Cytotherapy
|
March 23, 2020
Accelerating the development of innovative cellular therapy products for the treatment of cancer
Mark D Stewart, Anne Keane, Lisa H Butterfield, et al.
Critical Reviews in Oncology/Hematology
|
October 9, 2020
International liquid biopsy standardization alliance white paper
Dana Connors, Jeff Allen, J D Alvarez, et al.
JCO Clinical Cancer Informatics
|
July 24, 2019
An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung Cancer
Mark Stewart, Andrew D Norden, Nancy Dreyer, et al.
Journal for Immunotherapy of Cancer
|
September 22, 2025
Molecular response cutoffs and ctDNA collection timepoints influence on interpretation of associations between early changes in ctDNA and overall survival in patients treated with anti-PD(L)1 and/or chemotherapy
Hillary S Andrews, Nevine Zariffa, Katherine K Nishimura, et al.
Clinical Pharmacology and Therapeutics
|
October 16, 2021
Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot
Laura Lasiter, Olga Tymejczyk, Elizabeth Garrett-Mayer, et al.
Page
of 10